Cardio-cerebrovascular disease | Heart failure | circHRCR | Downregulated | Inhibits cardiac hypertrophy and heart failure by sponging miR-223 | [44] |
Myocardial infarction | circMFACR | Upregulated | Mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression | [47] |
Cardiac senescence | circFoxo3 | Upregulated | Promotes cardiac senescence by arrest ID-1, E2F1, FAK, and HIF1a in the cytoplasm | [18] |
| Atherosclerosis | circANRIL | Downregulated | Controls ribosome biogenesis through binding to PES1 and modulates pathways of atherogenesis | [45] |
| Coronary artery disease | hsa_circ_0124644 | Upregulated | Potential diagnostic biomarker of CAD in the peripheral blood | [46] |
| | hsa_circ_0001879 | Upregulated | A novel biomarker to diagnose CAD | [48] |
| | hsa_circ_0004104 | Upregulated | A novel biomarker to diagnose CAD | [48] |
| Stroke | circDLGAP | Downregulated | Ameliorates ischemic stroke outcomes by targeting miR-143 | [49] |
| | circHECTD1 | Upregulated | Contributes to astrocyte activation and cerebral infarction by targeting miR-142-TIPARP | [52] |
| | circFUNDC1 | Upregulated | Biomarker for AIS diagnosis and prediction of outcomes | [50] |
| | circPDS5B | Upregulated | Biomarker for AIS diagnosis and prediction of outcomes | [50] |
| | circCDC14A | Upregulated | Biomarker for AIS diagnosis and prediction of outcomes | [50] |
Neurodegenerative | Alzheimer's disease | ciRS-7 | Downregulated | Regulates the expression of UBE2A by sponging miR-7 | [57] |
disease | Parkinson’s disease | ciRS-7 | Upregulated | Modulates the α-synuclein aggregation pattern in PD by targeting miR-7 | [59] |
| Multiple system atrophy | circIQCK | Upregulated | Potential biomarker for MSA | [60] |
| | circMAP4K3 | Upregulated | Potential biomarker for MSA | [60] |
| | circEFCAB11 | Upregulated | Potential biomarker for MSA | [60] |
| | circDTNA | Upregulated | Potential biomarker for MSA | [60] |
| | circMCTP1 | Upregulated | Potential biomarker for MSA | [60] |
| Amyotrophic lateral sclerosis | hsa_circ_0023919 | Downregulated | Blood biomarker for ALS | [62] |
| | hsa_circ_0063411 | Upregulated | Blood biomarker for ALS | [62] |
| | hsa_circ_0088036 | Upregulated | Blood biomarker for ALS | [62] |
Cancer | Prostate cancer | circCSNK1G3 | Upregulated | Promotes cell growth by interacting with miR-181 | [65] |
| | circAMOTL1L | Downregulated | Facilitates cell migration and invasion through binding miR-193a-5p | [66] |
| | circ_0044516 | Upregulated | Promotes prostate cancer cell proliferation and metastasis and serves as a potential biomarker | [67] |
| Breast cancer | circCNOT2 | Upregulated | A useful biomarker to choose the right type of therapy or to monitor breast cancer | [68] |
| | circEPSTI1 | Upregulated | Regulates cell proliferation and apoptosis of TNBC by targeting BCL11A via miR-4753/6809 | [69] |
| | hsa_circ_001783 | Upregulated | Correlates with tumor burden and serves as a novel prognostic and therapeutic target for breast cancer | [70] |
| Colorectal cancer | circKLDHC10 | Upregulated | Potential circulating biomarker for CRC diagnosis | [56] |
| | circ_0001178 | Upregulated | Promising biomarker for liver metastases from CRC | [71] |
| | circ_0000826 | Upregulated | Promising biomarker for liver metastases from CRC | [71] |
| | circCCDC66 | Upregulated | Predictive biomarker for CRC detection and prognosis | [72] |
Diabetes | Diabetes | hsa_circ_0054633 | Upregulated | Circulating diagnostic biomarker for pre-diabetes and T2DM | [77] |
| | hsa_circ_11783-2 | Downregulated | Closely related to T2DM and might be novel therapeutic targets in diabetes | [78] |
| Diabetic retinopathy | circ_0005015 | Upregulated | Facilitates retinal endothelial angiogenic function via sponging miR-519d-3p | [80] |
| | circHIPK3 | Upregulated | Regulates retinal endothelial cell function and vascular dysfunction by sponging miR-30a | [81] |
| Diabetic cataract | circKMT2E | Upregulated | Involves in the pathogenesis of diabetic cataract | [82] |
Other diseases | Rheumatoid arthritis | hsa_circ_0044235 | Downregulated | Potential diagnostic biomarker of RA patients | [86] |
| Osteoporosis | circRUNX2 | Downregulated | Promotes the expression of osteogenic differentiation-related proteins by sponging miR-203 | [90] |
| | circ_0002060 | Upregulated | Potential diagnostic biomarker and therapeutic target in osteoporosis | [91] |